Overview
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
Source
Originally published at www.wired.com.
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
The FDA could decide whether to loosen rules around peptide production this week. Some telehealth players are already seeing dollar signs.
Originally published at www.wired.com.